HM
BLUE

HealthCor Management’s bluebird bio BLUE Stock Holding History

HealthCor Management’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-22,750
Closed -$2.88M – 30
2022
Q3 		$2.88M Buy
+22,750
New +$2.57M 0.36% 47
2020
Q3 		– Sell
-20,126
Closed -$15.9M – 45
2020
Q2 		$15.9M Sell
20,126
-27,909
-58% -$21M 0.67% 36
2020
Q1 		$28.6M Sell
48,035
-4,494
-9% -$4.38M 1.22% 27
2019
Q4 		$59.7M Buy
52,529
+13,382
+34% +$14.5M 2.13% 18
2019
Q3 		$46.6M Buy
39,147
+10,730
+38% +$16.4M 1.76% 23
2019
Q2 		$46.8M Buy
28,417
+5,034
+22% +$8.71M 1.82% 23
2019
Q1 		$47.7M Buy
+23,383
New +$41.2M 1.93% 21

Other funds holding BLUE

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

HealthCor Management's BLUE Position: Q4 2022 in Review

HealthCor Management sold out of bluebird bio (BLUE) in Q4 2022, closing a stake of 22,750 shares — an estimated $2.88M sold.

HealthCor Management first reported a position in BLUE in Q1 2019 and held it in 7 quarters. The position peaked at $59.7M in Q4 2019. 184 funds tracked by Wall St. Rank hold BLUE as of Q4 2022.

  • HealthCor Management reported no remaining bluebird bio position as of Q4 2022 after selling out during the quarter.
  • HealthCor Management sold 22,750 bluebird bio shares in Q4 2022, an estimated $2.88M.
  • HealthCor Management first reported a position in bluebird bio in Q1 2019 and held it in 7 quarters.
  • HealthCor Management's bluebird bio position peaked at $59.7M in Q4 2019.
  • 184 funds tracked by Wall St. Rank held bluebird bio as of Q4 2022.

Based on HealthCor Management's 13F filing for Q4 2022, filed 15 Feb 2023.